Looking look back on US wellness market developments and events in 2019, HBW Insight finds a firm that doesn’t compete in the dietary supplement sector, Amarin, made a good bit of news that affected the industry during the year. We track news across the wellness space from the past year.

OTC drug and dietary supplement industries still emphasize lobbying for allowing direct purchases of their [products with pre-tax health savings accounts; streamlining FDA's process for adding OTC monograph ingredients and indications; and making multivitamins eligible for purchase with food stamps. They also remain vigilant about keeping Congress' hands off DSHEA, which reaches its 25th anniversary in October.

House appoints its farm bill conference committee members primarily from Agriculture Committee but also with reps from committees with oversight for a variety of topics due to the breadth of the legislation and to contentious issues unrelated to including supplements as SNAP, or food stamp, benefits. Supplement industry also looks to fate of legislation that would allow using pre-tax health savings accounts to buy OTC drugs without having a doctor's prescription as a sign for whether VMS product purchases will be allowed with the accounts, as proposed in House and Senate bills.